We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSXMA
3676
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$1K ﹤0.01%
+26
New +$647
AVGR
3677
DELISTED
Avinger, Inc. Common Stock
AVGR
0
CTHR
3678
DELISTED
Charles & Colvard Ltd
CTHR
$1K ﹤0.01%
71
-45
-39% -$474
ICD
3679
DELISTED
Independence Contract Drilling, Inc.
ICD
$1K ﹤0.01%
5
-615
-99% -$68.9K
TRVN
3680
DELISTED
Trevena, Inc.
TRVN
-1
Closed -$3.58K
TTOO
3681
DELISTED
T2 Biosystems, Inc
TTOO
0
SOFO
3682
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
$1K ﹤0.01%
119
-607
-84% -$3.1K
AEY
3683
DELISTED
ADDvantage Technologies Group
AEY
$1K ﹤0.01%
38
-4
-10% -$70
TRHC
3684
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$1K ﹤0.01%
+61
New +$781
NMTR
3685
DELISTED
9 Meters Biopharma
NMTR
$1K ﹤0.01%
2
-2
-50% -$580
MLVF
3686
DELISTED
Malvern Bancorp, Inc.
MLVF
$1K ﹤0.01%
53
-457
-90% -$8.72K
KSPN
3687
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$1K ﹤0.01%
12
-39
-76% -$2.78K
AMOV
3688
DELISTED
America Movil SAB de CV
AMOV
$1K ﹤0.01%
105
-142
-57% -$1.61K
MYOV
3689
DELISTED
Myovant Sciences Ltd.
MYOV
$1K ﹤0.01%
+100
New +$1.16K
AHPI
3690
DELISTED
Allied Healthcare Products
AHPI
$1K ﹤0.01%
+600
New +$1.34K
AMPE
3691
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$1K ﹤0.01%
2
-2
-50% -$476
SRGA
3692
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$1K ﹤0.01%
+12
New +$1.1K
GWGH
3693
DELISTED
GWG Holdings, Inc
GWGH
$1K ﹤0.01%
66
-1,634
-96% -$13.5K
SUNS
3694
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
$1K ﹤0.01%
+71
New +$1.15K
ACBI
3695
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$1K ﹤0.01%
+47
New +$751
BMTC
3696
DELISTED
Bryn Mawr Bank Corp
BMTC
$1K ﹤0.01%
+33
New +$1.17K
EXFO
3697
DELISTED
EXFO INC.
EXFO
$1K ﹤0.01%
+312
New +$1.32K
MMAC
3698
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$1K ﹤0.01%
35
-638
-95% -$11.4K
SMTX
3699
DELISTED
SMTC Corporation
SMTX
$1K ﹤0.01%
796
+795
+79,500% +$1.12K
GSUM
3700
DELISTED
Gridsum Holding Inc.
GSUM
$1K ﹤0.01%
+92
New +$1.34K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.